The Fogg Lab aims to develop and exploit high throughput in vitro 3D models of cancer in order to identify novel druggable targets, improve treatment selection of current therapeutics, and reprogram the immune system in the metastatic niche. The insights gained from these studies will have broad relevance to the fields of drug discovery, immunotherapy, and precision medicine.